期刊文献+

激素性骨坏死骨质丢失与骨保护蛋白表达的相关研究 被引量:8

The relationship between bone-loss of steroid-induced osteonecrosis and local expression of OPG/OCIF
原文传递
导出
摘要 目的 探讨在激素性骨坏死的病程中 ,股骨不同部位骨保护蛋白 /破骨细胞形成抑制因子 (OPG/OCIF)的表达情况 ,与局部骨质丢失是否存在着相关性。 方法  31只新西兰白兔复制Yamamoto激素性骨坏死模型 ,内毒素和甲基强地松龙给药结束 3d后存活 2 4只 ;随机选 4只作为对照组 ,其余随机分为 4个不同时间组 ,每组 5只 ;按照不同时间组处死动物 ,进行股骨的骨密度值测量、病理切片H E染色和茜素红染色病理及OPG/OCIF组织化学染色 ,并进行图像处理和统计分析。结果 在激素性骨坏死早期 ,给药后 2周股骨的OPG/OCIF表达明显降低 (P <0 0 1) ,同时局部骨髓内出现了大量的破骨细胞 ;继而出现明显的骨质丢失 (从 0 375± 0 0 37、0 2 97± 0 0 2 2降至 0 173±0 0 2 4、0 183± 0 0 6 1,P <0 .0 5 )。 结论 糖皮质激素可抑制骨骼局部OPG/OCIF的表达 ,从而促进了破骨细胞分化与活性 ,加剧激素性坏死局部的骨质丢失。 Objective To probe the relationship between the osteoprotegerin/osteoclastogenesis inhibitory factor(OPG/OCIF) expression of bone and the relative bone loss. Methods Steroid induced osteonecrosis model was reproduced in thirty one new Zealand hares, and 24 ones were alive 3 days after administration of endotoxin and methylprednisolone. The alive creatures were divided into control group and trial groups randomly. After the creatures being executed, bone density measurement of the femurs, HE staining, Ca ++ staining and OPG/OCIF immunohistochemistry staining were performed, followed by image processing and statistical analysis. Results In the early period of steroid induced osteonecrosis, the local OPG/OCIF expression significantly decreased, with a large number of osteoclasts in the local medulla, followed by a progressively bone loss. Conclusion Corticosteroid could inhibit OPG/OCIF expression in the bone, increase the activity and differentiation of osteoclast relatively, and worsen bone loss in steroid induced osteonecrosis.
出处 《中华外科杂志》 CAS CSCD 北大核心 2002年第7期534-537,I004,共5页 Chinese Journal of Surgery
关键词 激素性骨坏死 骨质丢失 骨保护蛋白 相关研究 Osteonecrosis Glucocorticoids Osteoprotegerin/osteoclastogenesis inhibitory factor(OPG/OCIF)
  • 相关文献

参考文献10

  • 1Wong BR,Jaerang Rho,Arron J,et al.TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-jun N-terminal kinase in T cells[].Journal of Biological Chemistry.1997
  • 2Bucay N,Sarosi I,Dunstan CR,et al.Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification[].Genes and Development.1998
  • 3Akatsu T,Murakami T,Ono K,et al.Osteoclastogenesis inhibitory factor exhibits hypocalcemic eeffects normal mice and hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy[].Bone.1998
  • 4Kong YY,Yoshida H,Sarosi I,et al.OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogensis[].Nature.1999
  • 5Hofbauer LC,Gorl F,Riggs BL,et al.Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocoticoid-induced osteoporosis[].The Journal of Endocrinology.1999
  • 6Weinstein RS,Jilka RL,Parfitt AM,et al.Inhibition of osteoblastogenesis and promotion apoptosis of osteoblasts and osteocytes by glucocoticoids[].The Journal of Clinical Investigation.1998
  • 7Mont MA,Hungerford DS,Maryland B.Current ooncepts review nontraumatic avascular necrosis of the femoral head[].Journal of Bone and Joint Surgery British Volume.1995
  • 8Simonet WS,Lacey DL,Cunstan CR,et al.Osetoprotegerin: a novel secreted protein involved in the regulation of bone density[].Cell.1997
  • 9Mizuno A,Amizuka N,Irie K,et al.Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/ osteoprotegerin[].Biochemical and Biophysical Research Communications.1998
  • 10Yasuda H,Shima N,Nakagawa N,et al.A novel molelar mechanism modulating osteoclast differentiation and function[].Bone.1999

同被引文献158

引证文献8

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部